A study to compare whether Erbium glass laser alone or along with Injection Platelet rich plasma is effective for treatment of Strech marks (Striae Distensae)

A Comparative split study on efficacy of Er: glass non ablative fractional laser (1565 nm) with PRP vs Er: glass non ablative fractional laser (1565nm) alone in the treatment of Striae Distensae

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/11/059745

Enrollment

Registered

2023-11-10

Start date

Unknown

Completion date

Unknown

Last updated

2023-11-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L906- Striae atrophicae

Interventions

Intervention1: Er: glass non ablative fractional laser (1565 nm) and PRP (Platelet rich plasma): -Clean the area to be treated with antiseptic and normal saline. -Local anaesthetic (EMLA cream, a mixt

Eligibility

Inclusion criteria

Inclusion criteria: (i) Patients who are willing to participate in the study (ii) Patients with Fitzpatrick’s skin types III-VI (iii) Age group between 18- 40 years (iv) Bilateral striae distensae Patients who are willing to undergo the evaluation system and able to comply with all follow-up requirements.

Exclusion criteria

Exclusion criteria: (i) Patients who are not willing to participate in the study. (ii) Patients below 18 years and above 40 years. (iii) Pregnant and lactating women. (iv) Patients with history of active infections like Herpes, type I or II. (v) Dysplastic nevi (vi) Patients with history of photosensitive disorders like lupus erythematosus dermatomyositis. (vii) Chronic or cutaneous viral, fungal, or bacterial diseases (viii) Patients with history of propensity for keloid formation and vitiligo. (ix) Active cold sores, open lacerations or abrasions (x) Patients with implants, like dermal implants, pacemaker or cochlear implants. (xi) History or concurrent condition of skin cancer or pre-cancerous lesions (xii) Exposure to sun in the 4-6 weeks pre-op, or artificial tanning in the past 2-3 weeks pre op, remaining suntan, sunburn or artificially tanned skin (xiii) Tattoos (xiv) Patients who have received treatment for laser skin resurfacing in the past 6-12 months on the striae. (xv) Patients with unrealistic expectations, or not willing to give written informed consent.

Design outcomes

Primary

Measure	Time frame
Reduction in size and colour of strech marksTimepoint: 5 to 6 months	—

Secondary

Measure	Time frame
Reduction in size and colour of strech marksTimepoint: 4 to 6 weeks	—

Countries

India

Contacts

Public ContactDr Debdeep Mitra

Command Hospital Air Force Bangalore, Indian Air Force

debdeep5000@gmail.com08811851830

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026